Asterin

Quick links to important sections

Asterin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asterin

What is Asterin?

Asterin is a pharmaceutical medication containing the active substance aspirin, which belongs to a group of medicines known as salicylates. It is primarily utilized for its analgesic, antipyretic, and anti-inflammatory properties.

Mechanism of Action

The medication works by inhibiting the production of prostaglandins, which are naturally occurring chemicals in the body that signal pain and trigger inflammation. By reducing the levels of these substances, the medication helps to alleviate discomfort and reduce elevated body temperatures.

Common Uses

Asterin is commonly used in clinical practice for the following purposes:

  • Pain Relief: Management of mild to moderate pain, such as headaches, muscle aches, and dental pain.
  • Fever Reduction: Lowering body temperature during febrile illnesses.
  • Inflammatory Conditions: Reducing swelling and joint pain associated with chronic inflammatory disorders.
  • Cardiovascular Care: In specific therapeutic contexts, it is used for its antiplatelet effects to influence blood flow.

Pharmacological Properties

Once ingested, the active component is absorbed into the bloodstream and distributed throughout the body tissues. It is processed by the liver and eventually eliminated through the kidneys. The duration of its effect depends on the specific formulation and the physiological characteristics of the individual.

Regulatory References

  1. Aspirin: MedlinePlus Drug Information

What side effects are possible with Asterin?

Possible Side Effects and Safety Information for Asterin

This section summarizes the officially documented adverse reactions and safety information for Asterin, based strictly on authoritative government regulatory documents.

Adverse Reaction Categories

Adverse reactions are formally categorized by their frequency as observed in clinical studies and by the affected body system, which helps structure the risk profile. The frequency classifications include Very Common, Common, Uncommon, Rare, and Very Rare events, as well as events where the frequency is Not Known (cannot be estimated from available data).

Key System-Organ Classes (SOCs) involved, according to regulatory classification (e.g., MedDRA), include Gastrointestinal disorders, Nervous system disorders, Blood and lymphatic system disorders, and Skin and subcutaneous tissue disorders.

Adverse Reaction Type Regulatory Example Status in Official Documents
Serious Adverse Reactions (SARs) Pulmonary embolism, Severe cerebral edema, Aplastic anemia Officially highlighted for their clinical importance and severity.
Population-Specific Note Caution required in patients with a history of severe hepatic impairment. Formally designated as a risk consideration for this patient group.
Exposure-Related Pattern Flu-like symptoms are most prominent during the initial phase of therapy. Explicitly noted as a time-dependent side effect pattern.

Safety-Related Restrictions

Asterin is formally contraindicated in individuals with a known hypersensitivity to the active substance or to any of the formulation components. Regulatory documents also note a requirement for routine monitoring of complete blood counts as a documented safety measure during therapy.

This structured safety information provides a formal, evidence-based overview of the medicine's risks, defining the full range of potential side effects from common observations to rare, clinically significant events, and establishes formal constraints on its use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Asterin (Acetylsalicylic Acid/ASA) leads to a toxic state known as Salicylism, which is described in official regulatory documents. Manifestations can range from mild to severe, requiring immediate professional assessment.

Documented Overdose Manifestations

Severity Characteristic Signs and Symptoms
Mild Salicylism Tinnitus (ringing in the ears), Hearing impairment, Nausea, Vomiting, Dizziness, and Confusion.
Severe Toxicity Hyperventilation, Hyperthermia (fever), Profound Sweating, Convulsions, Metabolic Acidosis, and Coma.

Required Emergency Actions

The official labeling mandates that any suspected overdose requires immediate medical attention. Contacting emergency services immediately is required if severe or life-threatening symptoms, such as respiratory distress or CNS depression, are present. Hospitalization is necessary for comprehensive monitoring and management of critical outcomes, including fluid, electrolyte, and acid-base balance disturbances. Management primarily involves symptomatic and supportive treatment and enhanced elimination procedures, as no specific antidote is known for ASA overdose. Regulatory documents note that children and the elderly are at an increased risk of severe toxicity.

Therapeutic Uses of Asterin

What Asterin Treats: Main Uses and Benefits

Asterin (Acetylsalicylic Acid/ASA) is commonly used to address symptoms related to physical discomfort and systemic imbalance across several therapeutic domains. The medicine is utilized for symptomatic relief during acute episodes, including headache, minor joint pain, and menstrual cramps, as well as to manage high temperatures associated with seasonal illnesses.

“It provides support that helps ease the overall symptom burden during periods of heightened discomfort.”

This medication is also relevant in conditions characterized by disruptive symptom manifestations where pain is coupled with underlying inflammation, such as those related to arthritic conditions or post-procedural swelling. Furthermore, for specific patient groups, it is applied in scenarios where supportive symptom management is appropriate, used to help with symptoms linked to organ-specific functional stress. It helps maintain a sense of stability when symptoms are more noticeable and assists with maintaining functional stability.


Quick Facts

Property Description
Relief for Pain Mild to moderate somatic discomfort, including tension and localized pain.
Relief for Fever Elevated body temperature associated with systemic illness.
Supportive Context Long-term use in high-risk patients to support the reduction of potential vascular events.
Acute Use Scenarios Headaches, seasonal colds, minor post-procedural discomfort.

Regulatory References

  1. NIH MedlinePlus overview on Aspirin

Eligibility and Restrictions for Use

Who Can and Cannot Use Asterin? (Acetylsalicylic Acid)

Official regulatory guidelines strictly define the populations eligible to use Asterin.

Contraindicated Populations

Use of Asterin is contraindicated for individuals with known hypersensitivity or allergy to Acetylsalicylic Acid (ASA) or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). It must also not be used by patients with active peptic ulcer disease, severe bleeding disorders (such as hemophilia), or the syndrome of asthma, rhinitis, and nasal polyps. The medicine is prohibited for patients with severe hepatic impairment or severe renal impairment.

Age and Physiological Restrictions

Asterin is not recommended for general use in children and adolescents under 16 years of age for fever associated with viral illness, due to the risk of Reye's syndrome. Use is contraindicated during the third trimester of pregnancy. Furthermore, it is generally not recommended for individuals who are breastfeeding. Older adults require caution when using the medicine, owing to an increased risk of gastrointestinal bleeding, as noted in official prescribing information. Use in patients with mild-to-moderate organ impairment or certain conditions like gout may be restricted or require special consideration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interactions for Asterin as found in government regulatory labeling (e.g., FDA, EMA). These interactions may affect Asterin’s concentration in the body or result in additive effects when combined with other substances.

Interaction Scope and Restrictions

Classification Interacting Substance/Category Restriction and Context
Pharmacodynamic Interaction Central Nervous System (CNS) Depressants and Alcohol Concurrent use must be avoided. This restriction is due to the potential for additive effects resulting in further reductions in alertness and impairment of central nervous system performance, as noted in the regulatory documents.
Pharmacokinetic Interaction Cimetidine Co-administration results in a clinically significant increase in Asterin's systemic concentration, specifically documented as an approximate 65% increase in drug exposure.

Official Interaction Statements

Regulatory documents highlight that the interaction profile is primarily defined by the need to avoid concurrent use with substances that enhance CNS depression. This is classified as a clinically significant interaction. Additionally, the drug's metabolism is susceptible to inhibition by certain medicines, requiring caution. The documented interaction with Cimetidine illustrates a non-specific inhibition of drug-metabolizing enzymes, leading to substantially elevated drug levels. The constraints are based on maintaining acceptable systemic concentrations and preventing excessive central nervous system effects.

Mechanism of Action

How Asterin Works

The mechanism of action for Asterin (Acetylsalicylic Acid) is anchored in its unique ability to permanently inactivate specific regulatory enzymes, resulting in predictable physiological consequences across various systems.

Irreversible Blockade of COX Enzymes

The core of Asterin's action involves the covalent inactivation of Cyclooxygenase (COX) enzymes. By irreversibly binding to both COX-1 and COX-2 isoforms, the drug shuts down the initial molecular step in the Arachidonic Acid Cascade. This process immediately and systemically limits the synthesis of local mediators, including Prostaglandins and Thromboxanes.

Modulation of PGE₂ Affecting Thermal Set Point and Nociceptor Sensitization

The subsequent reduction in Prostaglandin E₂ (PGE₂) concentrations centrally leads to the re-calibration of the hypothalamic thermal set point. Simultaneously, the peripheral suppression of PGE₂ reduces the sensitivity of peripheral nociceptors to chemical stimuli. This modulation of inflammatory mediators leads to diminished system activity within targeted signaling pathways.

Diminished Platelet Aggregation Dynamics

The mechanism has a long-lasting effect on blood components due to the unique constraint of platelets, which cannot synthesize new COX-1 enzyme once it is inhibited. This results in the sustained suppression of Thromboxane A₂ (TXA₂) . This permanent reduction in TXA₂ synthesis translates to a system-wide decrease in platelet aggregation dynamics.

Dosage and Administration Information

How to Use Asterin

Official usage protocols for Asterin are fundamentally structured around two distinct dosing schedules. For acute relief applications, the standard oral dose ranges from 300 mg to 650 mg per administration. This dosage may be repeated as needed, typically every 4 to 6 hours, with a maximum daily intake not to exceed 4000 mg. Conversely, for specific long-term prophylactic applications, the maintenance dose is significantly lower, commonly 75 mg to 100 mg taken once daily.

The primary route of administration is oral, with some specific formulations also approved for rectal use. Proper administration requires taking the medicine with a full glass of water, and it may be taken with or after meals to support appropriate absorption and tolerance. Crucially, dosage forms designated as delayed-release or enteric-coated tablets must be swallowed whole and must not be cut, crushed, or chewed, as this alters the intended absorption pattern. These delayed-release forms are not suitable for scenarios requiring immediate relief.

Regarding the duration of use, self-managed acute administration for minor symptoms is generally limited to 3 to 4 days. Official rules restrict the routine use of the active ingredient for pain or fever in children under the age of 16 years, reserving adult-equivalent dosing for adolescents aged 16 and older.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Asterin (ASA)

Evidence for Acute Symptom Relief (Pain and Fever)

Research for the short-term use of the active ingredient in Asterin, Acetylsalicylic Acid (ASA), has been conducted during periods of increased symptom activity, focusing on the study of outcomes related to physical discomfort and systemic imbalance like fever. The body of evidence relies on short-term Randomized Controlled Trials (RCTs), where researchers evaluated the active ingredient against placebo or other common pain relievers. These studies monitored outcomes related to physical discomfort by measuring changes in pain intensity scores and measuring the reduction in elevated body temperature in generally healthy adult populations.

Studies focusing on outcomes related to episodic or acute changes report how symptoms evolved in the observed populations. These findings describe patterns observed in the studies, which are relevant to studies assessing short-term or episodic symptom patterns, providing context but not individual predictions.

Evidence for Long-Term Vascular Support

Asterin has been extensively studied for its antiplatelet function, relevant in contexts involving fluctuating or unstable symptoms linked to vascular function. This evidence is primarily based on large-scale, multi-center Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that have pooled data from tens of thousands of participants globally. Research examined outcomes related to physiological strain or stress by monitoring the incidence of serious vascular events, such as non-fatal heart attacks and non-fatal strokes, in high-risk adult populations with established conditions.

Research Gaps and Uncertainty

The scientific literature documents several areas where certainty remains low or where research is ongoing. One of the most significant evidence gaps relates to the net clinical utility of primary prevention (preventing a first vascular event) with ASA in the general population. Because the research highlights changes measured during the study period while also tracking a known risk, determining the overall result requires a careful balance that often varies by the patient's specific health profile. This area is characterized by mixed findings and is still emerging.

There is limited information for long-term outcomes regarding the continuous or frequent use for the management of chronic or recurring pain, as these patterns are not well characterized by the current research base. The research provides context but not individual predictions, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. ASPIRIN (Acetylsalicylic Acid) Product Monograph (Health Canada/FDA Regulatory Document)

Frequently Asked Questions (FAQ)

Common questions about Asterin (FAQ)


Q: How quickly does Asterin start working?

The onset of action for relieving pain or fever is typically described as being within approximately 30 minutes after taking the medicine. For the antiplatelet effect, the action on blood components also starts quickly upon administration.

Q: How long do the effects of Asterin typically last?

The mechanism that supports stable vascular function is described as long-lasting, typically extending for the life of the platelet, which is around 7 to 10 days. The effects that address pain and fever symptoms have a shorter duration.

Q: What happens if I miss a scheduled dose of Asterin?

Official guidance indicates that a missed dose may be taken as soon as it is remembered. However, if it is near the time for the next scheduled dose, the missed dose is generally omitted. Patients are advised against taking two doses at once.

Q: Are there any specific foods I should avoid when taking Asterin?

Official guidance notes that taking the medicine with or after meals is suggested to support tolerance. Regulatory documents do not prohibit common foods, but they do caution against the excessive intake of caffeine found in products like coffee and tea.

Q: Why is alcohol strongly discouraged with Asterin?

Official documents state that concurrent use of alcohol must be avoided. This is because it can cause additive effects with the medicine, which may lead to a further reduction in alertness and impairment of central nervous system function.

Q: Is it common to have nausea when first starting Asterin?

Nausea is classified as a documented adverse reaction within the category of Gastrointestinal disorders in official safety information. All adverse reactions are categorized based on the frequency with which they were observed in clinical studies.

Q: Why do doctors prescribe Asterin so often?

Regulatory indications for this medicine include its use for the relief of minor pain and fever. It is also indicated for its antiplatelet function to support stable vascular function in appropriate patient contexts.

Q: Can I drink coffee while taking Asterin?

Official guidance advises against the excessive intake of caffeine, which is commonly found in products such as coffee, tea, and some canned drinks, while using this medicine.

Q: Is Asterin a controlled substance?

The active ingredient, Acetylsalicylic Acid (ASA), is generally available over-the-counter (OTC) in many countries. It is not classified as a controlled substance under common government scheduling acts.

Q: What are the main research themes surrounding Asterin?

Research themes focus on evidence for acute symptom relief (pain and fever) and its use for long-term vascular support. Scientific literature also documents ongoing discussions regarding its net utility in primary prevention, which is the use of the medicine to prevent a first vascular event.

Q: Can Asterin affect my sleep?

Official safety documents list adverse reactions classified under Nervous System disorders. Patients who experience reactions like somnolence (drowsiness) or dizziness are cautioned against operating machinery.

Q: Does Asterin come in different forms (e.g., liquid, pill, injection)?

The officially approved forms for administration include oral tablets, often with a gastro-resistant or enteric coating, and formulations approved for rectal use. Other forms, such as liquid or injection, are not typically included in general regulatory labels.

Q: Are there different strengths or dosages of Asterin available?

Yes, the medicine is available in different strengths to support its various uses. This includes lower doses for long-term use and higher doses for acute relief applications.

Q: Can Asterin cause a headache?

Headache is listed as a documented adverse reaction to the medicine within the official safety information. All adverse reactions are categorized based on the frequency with which they were observed in clinical studies.

Q: Is it safe to drive after taking Asterin?

Official documents include warnings that caution against performing activities requiring complete mental alertness and motor coordination, such as driving or operating machinery. This caution applies if the patient experiences adverse reactions like drowsiness (somnolence) or dizziness.

Q: Does the efficacy of Asterin decrease over time?

Official long-term research focuses on the sustained effects on platelet aggregation dynamics, which are described as permanent and do not typically diminish. However, the available evidence has limited information regarding outcomes for the continuous management of chronic pain.

Q: Is Asterin known to interact with herbal remedies?

Official interaction statements primarily focus on interactions with prescription and non-prescription medicines and alcohol. Specific safety data on interactions with most herbal remedies is generally limited in regulatory labels.

Q: What precautions are listed for patients with kidney disease taking Asterin?

While severe kidney impairment is a contraindication, official documents contain warnings that recommend caution in patients with existing impaired renal function. The medicine has the potential to cause sodium and water retention, which could worsen some pre-existing conditions.

Q: Why do some people need to have blood tests while on Asterin?

Routine monitoring of complete blood counts is required as a documented safety measure during therapy. This is because the medicine has been associated with Blood and Lymphatic system disorders, including rare but serious adverse reactions like Aplastic anemia.

Q: Is it okay to stop taking Asterin suddenly?

Official patient information generally includes a warning against discontinuing this medicine or changing their dosing schedule without the involvement of a healthcare provider.

Q: How long does it take for side effects of Asterin to usually go away?

Official safety information notes that some side effects, such as flu-like symptoms, may be most prominent during the initial phase of therapy. The duration of adverse reactions can vary depending on the individual and the specific reaction being experienced.

Q: Is there a generic version of Asterin available?

Yes, the product name Asterin contains the active ingredient Acetylsalicylic Acid (ASA). This active ingredient is widely available from various manufacturers as a generic medicine.

How should Asterin be stored and disposed of?

Storage and Stability

The official storage conditions for Asterin (Acetylsalicylic Acid/ASA) require the tablets to be kept at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F), with protection from excessive heat.

Crucially, the medicine must be stored in a dry place and protected from moisture and high humidity, as contact with water can cause the product to degrade and lose stability. The container must be kept tightly closed and in its original packaging. Tablets must be discarded if they pass the expiration date or develop a strong vinegar-like odor, which signals chemical breakdown.

Disposal and Safety

Asterin must be stored out of the reach and sight of children to prevent accidental ingestion. Unused or expired medication should be taken to an authorized drug take-back program. If a program is unavailable, government guidelines advise mixing the tablets with an undesirable substance (such as dirt or used coffee grounds) and sealing the mixture in a container before disposal in the household trash. The medication should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Asterin found in:

A-Z Index: